FRONTIER CAPITAL MANAGEMENT CO LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 217 filers reported holding IMMUNOMEDICS INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.6%.

Quarter-by-quarter ownership
FRONTIER CAPITAL MANAGEMENT CO LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2020$21,511,000
+28.5%
606,968
-51.1%
0.19%
+1.1%
Q1 2020$16,742,000
-34.0%
1,241,977
+3.5%
0.19%0.0%
Q4 2019$25,382,000
+68.9%
1,199,517
+5.9%
0.19%
+59.3%
Q3 2019$15,024,000
+57.5%
1,133,018
+64.8%
0.12%
+63.9%
Q2 2019$9,537,000
-54.3%
687,617
-36.7%
0.07%
-51.4%
Q1 2019$20,859,0001,085,8540.15%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders